Improving Diversity and Inclusion in Clinical Trials
-
Register
- Non-member - $8
- Member - Free!
Already registered?
Log in now.
- Describe the importance of including diverse populations in clinical trials
- Identify strategies to improve diversity, inclusion, and equity in clinical trials
- List barriers or perceptions that prevent or limit diversity, inclusion, and equity in clinical trials
F. Diane Barber
PhD, ANP-BC, AOCNP, FAANP, FAAN
Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program) University of Texas MD Anderson Cancer Center
F. Diane Barber has no relevant financial disclosures
Key:
Complete
Next
Failed
Available
Locked
Pre-Test: Improving Diversity and Inclusion in Clinical Trials
3 Questions | 1 attempt | 0/3 points to pass | Graded as Pass/Fail
3 Questions | 1 attempt | 0/3 points to pass | Graded as Pass/Fail
This pre-test is designed to assess your current knowledge on this topic. Please answer the questions to the best of your ability. There is no time limit and your response will be kept confidential. This is required to move on to the next component.
Post-Test: Improving Diversity and Inclusion in Clinical Trials
3 Questions | 3 attempts | 3/3 points to pass
3 Questions | 3 attempts | 3/3 points to pass
This post-test is required to earn your CE certificate. You must answer all the questions correctly to earn credit for this module. You have 3 attempts to pass the post-test.
Evaluation: Improving Diversity and Inclusion in Clinical Trials
17 Questions
17 Questions
Please review and answer all the required questions.
